Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study
Vasiliki Kroustali, Esmeralda Resoulai, Lamprini Kanioura, Maria Siopi, Joseph Meletiadis, Stavroula AntonopoulouABSTRACT
Background
The epidemiology of vulvovaginal candidiasis (VVC) in Greece remains poorly reported and outdated.
Objectives
We therefore conducted a 2‐year retrospective survey to assess the epidemiological aspects of the infection among symptomatic Greek patients.
Patients/Methods
High vaginal swab samples were collected from adult women with clinically suspected VVC attending a private diagnostic laboratory in Athens. VVC was confirmed through microscopic examination of a wet mount preparation revealing yeasts and Candida‐positive culture. Species were identified by MALDI‐ToF MS, and in vitro susceptibility was determined according to the EUCAST‐E.Def 7.4. Predisposing host factors were associated with the occurrence of the infection and isolated Candida spp. using Fisher's exact test, and epidemiological changes over time were analysed with the χ2 test for trend.
Results
Among 1300 women screened, 283 VVC episodes were recorded among 233 (18%) patients, whereof 11 (5%) had recurrent VVC (RVVC) and 19 (8%) had mixed Candida infections. Coinfection with other pathogens and recent prior use of antifungals were associated with RVVC. Candida albicans was the most prevalent pathogen (50%), followed by
Conclusions
VVC is common in our region, with